Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Baxter
AstraZeneca
Colorcon
Boehringer Ingelheim

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Iodophenyl

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Iodophenyl?

Iodophenyl is an investigational drug.

There have been 9 clinical trials for Iodophenyl. The most recent clinical trial was a Phase 2 trial, which was initiated on July 12th 2017.

The most common disease conditions in clinical trials are Parkinson Disease, Alcoholism, and Alcohol Drinking. The leading clinical trial sponsors are Cellectar Biosciences, Inc., Neurobiology Research Unit, Rigshospitalet, Copenhagen, and GE Healthcare.

There are two US patents protecting this investigational drug and twenty-eight international patents.

Recent Clinical Trials for Iodophenyl
TitleSponsorPhase
Trametinib and TAS-102 in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by SurgeryCity of Hope Medical CenterPhase 1
Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?Neurobiology Research Unit, Rigshospitalet, CopenhagenPhase 2
Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?Section of Biostatistics University of Copenhagen, CopenhagenPhase 2

See all Iodophenyl clinical trials

Clinical Trial Summary for Iodophenyl

Top disease conditions for Iodophenyl
Top clinical trial sponsors for Iodophenyl

See all Iodophenyl clinical trials

US Patents for Iodophenyl

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Iodophenyl   Start Trial Method for preparing nilotinib ASYMCHEM LABORATORIES (TIANJIN) CO., LTD (Teda Tianjin, CN) TIANJIN ASYMCHEM PHARMACEUTICAL CO., LTD (Tianjin, CN) JILIN ASYMCHEM LABORATORIES CO., LTD (Jilin, CN) ASYMCHEM LIFE SCIENCE (TIANJIN) CO., LTD (Teda Tianjin, CN) ASYMCHEM LABORATORIES (FUXIN) CO., LTD (Liaoning, CN)   Start Trial
Iodophenyl   Start Trial Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders Dana-Farber Cancer Institute, Inc. (Boston, MA)   Start Trial
Iodophenyl   Start Trial Compound and organic light-emitting device including the same Samsung Display Co., Ltd. (Yongin-si, KR)   Start Trial
Iodophenyl   Start Trial Cationic polymerizable compositions and methods of use thereof STRATASYS LTD. (Rehovot, IL)   Start Trial
Iodophenyl   Start Trial Modulators of the retinoid-related orphan receptor gamma (ROR-gamma) for use in the treatment of autoimmune and inflammatory diseases Glaxo Group Limited (GB)   Start Trial
Iodophenyl   Start Trial Syk inhibitors Gilead Sciences, Inc. (Foster City, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Iodophenyl

Drugname Country Document Number Estimated Expiration Related US Patent
Iodophenyl European Patent Office 3305777 2035-05-26   Start Trial
Iodophenyl World Intellectual Property Organization (WIPO) 2016187824 2035-05-26   Start Trial
Iodophenyl Australia 2011210567 2030-01-29   Start Trial
Iodophenyl Canada 2787784 2030-01-29   Start Trial
Iodophenyl European Patent Office 2528893 2030-01-29   Start Trial
Iodophenyl European Patent Office 3138838 2030-01-29   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
AstraZeneca
Baxter
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.